Senior insider sale
Chief Executive Officer at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$8.76M
280.09K shares
What this filing means
DUBE ERIC M plans to sell 280.09K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $8.76M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/1/2026ACC: 0001959173-26-002715
DirectorOfficer· Chief Executive Officer
Since Jan 2019
280.09K
Shares to sell
$8.76M
Approx. market value
60K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Option Granted - 01/31/2020
Cash
4/1/2026
60KTotal acquired60K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/1/2026 | Option Granted - 01/31/2020 Cash | 60K | — |
| Total | 60K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
60K
Market value
$1.81M
2/20/2026
—Completed
Units to sell
100.09K
Market value
$3.29M
2/3/2026
—Completed
Units to sell
51.87K
Market value
$1.56M
1/27/2026
—Completed
Units to sell
8.13K
Market value
$244.2K
1/23/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
60K
Market value
$1.86M
4/1/2026
Total
Units
280.09K
Value
$8.76M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/20/2026 | 60K | $1.81M | — | Completed |
2/3/2026 | 100.09K | $3.29M | — | Completed |
1/27/2026 | 51.87K | $1.56M | — | Completed |
1/23/2026 | 8.13K | $244.2K | — | Completed |
| Planned — Approximate Date | ||||
4/1/2026 | 60K | $1.86M | NASDAQ | Planned |
| Total | 280.09K | $8.76M | ||